If you've been using eye-whitening drops to brighten your eyes, you may want to stop.

Keratopigmentation could be dangerous, doctors warn. Patients say it's worth the risks.

Livionex, recently announced a successful end-of-Phase 2 meeting with the FDA, supporting the advancement of C-KAD, a 2.6% EDTA ophthalmic solution, to a Phase 3 clinical study. In an interview with ...

It’s been a year since the gene-editing treatment Casgevy was approved for sickle cell disease and a related blood disorder.

Solawave is known for creating healthy, nourishing skincare products that use light — we talk about why we love the eye ...

It happens when a parasite that can be found in water invades the eye, damaging the cornea, causing severe pain and ...

EyePoint Pharmaceuticals' lead product, EYP-1901, shows promising phase 2 results for wet AMD and DME. Read more about EYPT ...

A new treatment that could prevent blindness in children with the CLN2 type Batten disease has been trialed by clinicians and ...

In case of bilateral involvement, only one eye (the left) of each patient was included. Exclusion criteria included a diagnosis of glaucoma, ocular hypertension or prior vitrectomy surgery in the ...

Researchers Jennifer Loh, MD, of Loh Ophthalmology Associates in Glenvar Heights, Florida, and Preeya Gupta, MD, of Triangle Eye Associates in Raleigh, North Carolina evaluated 613 patients between 45 ...

The Food and Drug Administration will allow a new device to be marketed as a treatment for dry age-related macular degeneration.

The images reveal what looks like a pair of “blood-soaked” eyes staring into the cosmos, giving the galaxies an eerie, otherworldly appearance. Despite their menacing look, these galaxies are ...